The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling
Open accessAbstract
BACKGROUND: The existing estimate of the global burden of latent TB infection (LTBI) as "one-third" of the world population is nearly 20 y old. Given the importance of controlling LTBI as part of the End TB Strategy for eliminating TB by 2050, changes in demography and scientific understanding, and progress in TB control, it is important to re-assess the global burden of LTBI. METHODS AND FINDINGS: We constructed trends in annual risk in infection (ARI) for countries between 1934 and 2014 using a combination of direct estimates of ARI from LTBI surveys (131 surveys from 1950 to 2011) and indirect estimates of ARI calculated from World Health Organisation (WHO) estimates of smear positive TB prevalence from 1990 to 2014. Gaussian process regression was used to generate ARIs for country-years without data and to represent uncertainty. Estimated ARI time-series were applied to the demography in each country to calculate the number and proportions of individuals infected, recently infected (infected within 2 y), and recently infected with isoniazid (INH)-resistant strains. Resulting estimates were aggregated by WHO region. We estimated the contribution of existing infections to TB incidence in 2035 and 2050. In 2014, the global burden of LTBI was 23.0% (95% uncertainty interval [UI]: 20.4%-26.4%), amounting to approximately 1.7 billion people. WHO South-East Asia, Western-Pacific, and Africa regions had the highest prevalence and accounted for around 80% of those with LTBI. Prevalence of recent infection was 0.8% (95% UI: 0.7%-0.9%) of the global population, amounting to 55.5 (95% UI: 48.2-63.8) million individuals currently at high risk of TB disease, of which 10.9% (95% UI:10.2%-11.8%) was isoniazid-resistant. Current LTBI alone, assuming no additional infections from 2015 onwards, would be expected to generate TB incidences in the region of 16.5 per 100,000 per year in 2035 and 8.3 per 100,000 per year in 2050. Limitations included the quantity and methodological heterogeneity of direct ARI data, and limited evidence to inform on potential clearance of LTBI. CONCLUSIONS: We estimate that approximately 1.7 billion individuals were latently infected with Mycobacterium tuberculosis (M.tb) globally in 2014, just under a quarter of the global population. Investment in new tools to improve diagnosis and treatment of those with LTBI at risk of progressing to disease is urgently needed to address this latent reservoir if the 2050 target of eliminating TB is to be reached.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“An estimated 1.7 billion have tuberculosis infections that are “latent.”56”
From Global health 2050: the path to halving premature death by mid-century (2024) · cites this paper as [56]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dye, C., Scheele, S., >Dolin, P., Pathania, V. S., Raviglione, M. C., & for the WHO Global Surveillance and Monitoring Project (1999) · JAMA · doi:10.1001/jama.282.7.677 · Cited by 2,955
The Growing Burden of Tuberculosis: Global Trends and Interactions With the HIV Epidemic
Corbett, E. L., Watt, C. J., Walker, N., Maher, D., Williams, B. G., Raviglione, M. C., & Dye, C. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.9.1009 · Cited by 2,553
Uplekar, M., Weil, D., Lonnroth, K., Jaramillo, E., Lienhardt, C., Dias, H. M., Falzon, D., Floyd, K., Gargioni, G., Getahun, H., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60570-0 · Cited by 1,117
Trunz, B. B., Fine, P., & Dye, C. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68507-3 · Cited by 1,114
Gamma Interferon Release Assays for Detection of Mycobacterium tuberculosis Infection
Pai, M., Denkinger, C. M., Kik, S. V., Rangaka, M. X., Zwerling, A. A., Oxlade, O., Metcalfe, J. Z., Cattamanchi, A., Dowdy, D. W., Dheda, K. U. J., et al. (2014) · Clinical Microbiology Reviews · doi:10.1128/cmr.00034-13 · Cited by 881
A blood RNA signature for tuberculosis disease risk: a prospective cohort study
Zak, D. E., Penn‐Nicholson, A., Scriba, T. J., Thompson, E. G., Suliman, S., Amon, L. M., Mahomed, H., Erasmus, M., Whatney, W. E., Hussey, G. D., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01316-1 · Cited by 779
Latent Mycobacterium tuberculosis Infection
Getahun, H., Matteelli, A., Chaisson, R. E., & Raviglione, M. C. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1405427 · Cited by 776
Vynnycky, E., & Fine, P. (1997) · Epidemiology and Infection · doi:10.1017/s0950268897007917 · Cited by 562
Rangaka, M. X., Wilkinson, K. A., Glynn, J. R., Ling, D. I., Menzies, D., Mwansa-Kambafwile, J. R. M., Fielding, K., Wilkinson, R. J., & Pai, M. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70210-9 · Cited by 475
Burden of childhood tuberculosis in 22 high-burden countries: a mathematical modelling study
Dodd, P. J., Gardiner, E., Coghlan, R., & Seddon, J. A. (2014) · The Lancet Global Health · doi:10.1016/s2214-109x(14)70245-1 · Cited by 368
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 301–400 of 1,001
Campbell, C., Andersson, M. I., Ansari, M. A., Moswela, O., Misbah, S., Klenerman, P., & Matthews, P. C. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.706482 · Cited by 37
Robison, H. M., Chapman, C. A., Zhou, H., Erskine, C. L., Theel, E. S., Peikert, T., Arlehamn, C. S. L., Sette, A., Bushell, C., Welge, M. E., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-99754-3 · Cited by 36
Jiang, F., Peng, C., Cheng, P., Wang, J., Lian, J., & Gong, W. (2023) · Vaccines · doi:10.3390/vaccines11040856 · Cited by 37
Infections in Patients with Rheumatoid Arthritis in the Era of Targeted Synthetic Therapies
Thomas, Κ., & Vassilopoulos, D. (2020) · Mediterranean Journal of Rheumatology · doi:10.31138/mjr.31.1.129 · Cited by 37
Rickman, H. M., Phiri, M. D., Feasey, H. R. A., Krutikov, M., Shao, H., Horton, K. C., Dowdy, D. W., Nightingale, E., Dodd, P. J., Corbett, E. L., et al. (2025) · The Lancet Public Health · doi:10.1016/s2468-2667(25)00120-3 · Cited by 36
Self-citationProtective immunity against tuberculosis: what does it look like and how do we find it?
Huang, L., & Russell, D. G. (2017) · Current Opinion in Immunology · doi:10.1016/j.coi.2017.08.001 · Cited by 37
Modulating Iron for Metabolic Support of TB Host Defense
Phelan, J. J., Basdeo, S. A., Tazoll, S. C., McGivern, S., Saborido, J. R., & Keane, J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02296 · Cited by 37
Trajman, A., Wakoff-Pereira, M. F., Ramos-Silva, J., Cordeiro‐Santos, M., de Albuquerque, M. D. F. P. M., Hill, P. C., & Menzies, D. (2019) · BMC Health Services Research · doi:10.1186/s12913-019-4231-x · Cited by 36
Waters, R., Ndengane, M., Abrahams, M.-R., Diedrich, C. R., Wilkinson, R. J., & Coussens, A. K. (2020) · Future Virology · doi:10.2217/fvl-2019-0069 · Cited by 35
Suliman, A. M., Bek, S. A. H., Elkhatim, M. S., Husain, A., Mismar, A. Y., Eldean, M. Z. S., Lengyel, Z., Elazzazy, S., Rasul, K. I., & Omar, N. E. (2020) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-020-02726-1 · Cited by 35
Longitudinal Dynamics of a Blood Transcriptomic Signature of Tuberculosis
Mulenga, H., Musvosvi, M., Mendelsohn, S. C., Penn‐Nicholson, A., Mbandi, S. K., Fiore-Gartland, A. J., Tameris, M. D., Mabwe, S., Africa, H., Bilek, N., et al. (2021) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202103-0548oc · Cited by 33
Amelio, P., Portevin, D., Reither, K., Mhimbira, F., Mpina, M., Tumbo, A., Nickel, B., Marti, H., Knopp, S., Ding, S.-W., et al. (2017) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0005817 · Cited by 38
Infection free “resisters” among household contacts of adult pulmonary tuberculosis
Mave, V., Padmapriyadarshini, C., Chavan, A., Shivakumar, S. V. B. Y., Danasekaran, K., Paradkar, M., Thiruvengadam, K., Kinikar, A. A., Murali, L., Gaikwad, S., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0218034 · Cited by 36
Novel therapeutic approaches to psoriasis and risk of infectious disease
Motolese, A., Ceccarelli, M., Macca, L., Li Pomi, F., Ingrasciotta, Y., Nunnari, G., & Guarneri, C. (2022) · Biomedicines · doi:10.3390/biomedicines10020228 · Cited by 35
Jeong, Y., & Min, J. (2023) · Journal of Korean Medical Science · doi:10.3346/jkms.2023.38.e43 · Cited by 35
Prevalence and risk factors for latent tuberculosis infection among healthcare workers in Morocco
Sabri, A., Quistrebert, J., Amrani, H. N., Abid, A., Zegmout, A., Ghorfi, I. A., Souhi, H., Boucaid, A., Benali, A., Abilkassem, R., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0221081 · Cited by 35
Lawal, I. O., Fourie, B. P., Mathebula, M., Moagi, I., Lengana, T., Moeketsi, N., Nchabeleng, M., Hatherill, M., & Sathekge, M. M. (2019) · Journal of Nuclear Medicine · doi:10.2967/jnumed.119.233783 · Cited by 35
High risk of activation of latent tuberculosis infection in rheumatic disease patients
Long, W., Cai, F., Wang, X., Zheng, N., & Wu, R. (2019) · Scandinavian Journal of Infectious Diseases · doi:10.1080/23744235.2019.1682187 · Cited by 35
Recent Developments in Tuberculous Meningitis Pathogenesis and Diagnostics
Cresswell, F. V., Davis, A., Sharma, K., Roy, R. B., Ganiem, A. R., Kagimu, E., Solomons, R., Wilkinson, R. J., Bahr, N. C., & Thương, N. T. T. (2019) · Wellcome Open Research · doi:10.12688/wellcomeopenres.15506.3 · Cited by 43
Lü, P., Liu, Q., Zhou, Y., Martínez, L., Kong, W., Ding, X., Peng, X., Zhu, T., Zhu, L., & Lu, W. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa519 · Cited by 35
Oxlade, O., Benedetti, A., Adjobimey, M., Alsdurf, H., Anagonou, S., Cook, V. J., Fisher, D., Fox, G. J., Fregonese, F., Hadisoemarto, P. F., et al. (2021) · The Lancet Public Health · doi:10.1016/s2468-2667(20)30261-9 · Cited by 35
Zhang, H., Dai, X., Hu, P., Tian, L., Li, C., Ding, B., Yang, X., & He, X. (2024) · Microbiology Spectrum · doi:10.1128/spectrum.04098-23 · Cited by 34
Translational regulation in mycobacteria and its implications for pathogenicity
Sawyer, E. B., Grabowska, A. D., & Cortes, T. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky574 · Cited by 35
Park, H., Back, Y. W., Shin, K., Bae, H. S., Lee, K.-I., Choi, H., Choi, S., Lee, H.-H., Choi, C. H., Park, J., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-38982-0 · Cited by 34
Active Tuberculosis in Patients with Psoriasis Receiving Biologic Therapy: A Systematic Review
Snast, I., Bercovici, E., Solomon‐Cohen, E., Avni, T., Shitenberg, D., Hodak, E., & Pavlovsky, L. (2019) · American Journal of Clinical Dermatology · doi:10.1007/s40257-019-00432-y · Cited by 34
Dolla, C. K., Padmapriyadarsini, C., Thiruvengadam, K., Lokhande, R., Kinikar, A. A., Paradkar, M., Shrinivas, B. M., Murali, L., Gupte, A., Gaikwad, S., et al. (2019) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1093/trstmh/trz049 · Cited by 34
Epidemiology of Tuberculosis in the United States
Langer, A. J., Navin, T. R., Winston, C. A., & LoBue, P. A. (2019) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2019.07.001 · Cited by 34
Country-specific intervention strategies for top three TB burden countries using mathematical model
Kim, S., Reyes, A. A. D. L., V, & Jung, E. (2020) · PLoS ONE · doi:10.1371/journal.pone.0230964 · Cited by 34
Harries, A. D., Kumar, A. M. V., Satyanarayana, S., Thekkur, P., Lin, Y., Dlodlo, R. A., Khogali, M. A., & Zachariah, R. (2020) · Tropical Medicine and Infectious Disease · doi:10.3390/tropicalmed5020061 · Cited by 37
Cancer risk in tuberculosis patients in a high endemic area
Chen, G., Guo, L., Shun-e, Y., & Ji, D. (2021) · BMC Cancer · doi:10.1186/s12885-021-08391-6 · Cited by 34
Bhargava, A., Bhargava, M., Velayutham, B., Thiruvengadam, K., Watson, B., Kulkarni, B., Singh, M., Dayal, R., Pathak, R. R., Mitra, A., et al. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-047210 · Cited by 34
Public–Private Mix Models of Tuberculosis Care in Pakistan: A High-Burden Country Perspective
Ullah, W., Wali, A., Haq, M. U., Yaqoob, A., Fatima, R., & Khan, G. M. (2021) · Frontiers in Public Health · doi:10.3389/fpubh.2021.703631 · Cited by 34
Lipid-Laden Macrophages in Pulmonary Diseases
Zhu, Y., Choi, D., Somanath, P. R., & Zhang, D. (2024) · Cells · doi:10.3390/cells13110889 · Cited by 35
Mehmood, A., Khan, M. T., Kaushik, A. C., Khan, A. S., Irfan, M., & Wei, D. (2019) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2019.00404 · Cited by 33
Latent Tuberculosis and HIV Infection
Bares, S. H., & Swindells, S. (2020) · Current Infectious Disease Reports · doi:10.1007/s11908-020-00726-x · Cited by 33
Local Pulmonary Immunological Biomarkers in Tuberculosis
Morrison, H., & McShane, H. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.640916 · Cited by 33
Tuberculosis: The Past, the Present and the Future
Koegelenberg, C. F. N., Schoch, O. D., & Lange, C. G. (2021) · Respiration · doi:10.1159/000516509 · Cited by 33
Treatment of Latent Tuberculosis Infection
Haley, C. A. (2017) · Microbiology Spectrum · doi:10.1128/microbiolspec.tnmi7-0039-2016 · Cited by 33
Challenges and the Way forward in Diagnosis and Treatment of Tuberculosis Infection
Chin, K. L., Anibarro, L., Sarmiento, M. E., & Acosta, A. (2023) · Tropical Medicine and Infectious Disease · doi:10.3390/tropicalmed8020089 · Cited by 32
Ryckman, T. S., Weiser, J., Gombe, M., Turner, K., Soni, P., Tarlton, D., Mazhidova, N., Churchyard, G., Chaisson, R. E., & Dowdy, D. W. (2023) · The Lancet Global Health · doi:10.1016/s2214-109x(23)00251-6 · Cited by 32
Zhou, F., & Zhang, D. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1238649 · Cited by 37
Tuberculosis: Current Status, Diagnosis, Treatment and Development of Novel Vaccines
Yadav, J., Verma, S., Chaudhary, D., Jaiwal, P. K., & Jaiwal, R. (2019) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201020666190430114121 · Cited by 32
One Size Fits All? Not in In Vivo Modeling of Tuberculosis Chemotherapeutics
Yang, H., Wang, D., Wen, X., Weiner, D. M., & Via, L. E. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.613149 · Cited by 33
Simmons, J. D., Van, P. T., Stein, C. M., Chihota, V. N., Ntshiqa, T., Maenetje, P. W., Peterson, G. J., Reynolds, A., Benchek, P. H., Velen, K., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci140073 · Cited by 29
Indoor Air Pollution and Susceptibility to Tuberculosis Infection in Urban Vietnamese Children
Blount, R. J., Phan, H., Trinh, T., Dang, H., Merrifield, C., Zavala, M., Zabner, J., Comellas, A. P., Stapleton, E. M., Segal, M. R., et al. (2021) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202101-0136oc · Cited by 32
Clinical analysis of pregnancy complicated with miliary tuberculosis
Wang, K., Ren, D., Qiu, Z., & Li, W. (2021) · Annals of Medicine · doi:10.1080/07853890.2021.2018485 · Cited by 32
Alterations in the Gut Microbiome of Individuals With Tuberculosis of Different Disease States
Wang, Y., Deng, Y., Liu, N., Chen, Y., Jiang, Y., Teng, Z., Ma, Z., Chang, Y., & Xiang, Y. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.836987 · Cited by 32
The pathogenic mechanism of Mycobacterium tuberculosis: implication for new drug development
Yan, W., Zheng, Y., Dou, C. R., Zhang, G., Arnaout, T., & Cheng, W. (2022) · Molecular Biomedicine · doi:10.1186/s43556-022-00106-y · Cited by 35
Moran, E., Baharani, J., Dedicoat, M. J., Robinson, E., Smith, G., Bhomra, P., Thein, O. S., & Ryan, R. M. (2018) · Journal of Infection · doi:10.1016/j.jinf.2018.06.003 · Cited by 31
Abubakar, I., Lalvani, A., Southern, J., Sitch, A. J., Jackson, C., Onyimadu, O., Lipman, M. C. I., Deeks, J. J., Griffiths, C., Bothamley, G. H., et al. (2018) · Health Technology Assessment · doi:10.3310/hta22560 · Cited by 31
Keshavjee, S. A., Amanullah, F., Cattamanchi, A., Chaisson, R. E., Dobos, K. M., Fox, G. J., Gendelman, H. E., Gordon, R. K., Hesseling, A. C., Van, H. L., et al. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201806-1053pp · Cited by 31
PPE17 (Rv1168c) protein of Mycobacterium tuberculosis detects individuals with latent TB infection
Abraham, P. R., Devalraju, K. P., Jha, V., Valluri, V. L., & Mukhopadhyay, S. (2018) · PLoS ONE · doi:10.1371/journal.pone.0207787 · Cited by 31
The generation of T‐cell memory to protect against tuberculosis
Counoupas, C., & Triccas, J. A. (2019) · Immunology and Cell Biology · doi:10.1111/imcb.12275 · Cited by 30
Forecasting the impact of population ageing on tuberculosis incidence
Ku, C.-C., & Dodd, P. J. (2019) · PLoS ONE · doi:10.1371/journal.pone.0222937 · Cited by 31
Self-citationBastos, M. L., Campbell, J. R., Oxlade, O., Adjobimey, M., Trajman, A., Ruslami, R., Kim, H. J., Baah, J. O., Toelle, B. G., Long, R., et al. (2020) · Annals of Internal Medicine · doi:10.7326/m19-3741 · Cited by 31
Satyanarayana, S., Thekkur, P., Kumar, A. M. V., Lin, Y., Dlodlo, R. A., Khogali, M. A., Zachariah, R., & Harries, A. D. (2020) · Tropical Medicine and Infectious Disease · doi:10.3390/tropicalmed5020101 · Cited by 34
Martins‐Melo, F. R., Bezerra, J. M. T., Barbosa, D. S., Carneiro, M., Andrade, K. B., Ribeiro, A. L. P., Naghavi, M., & Werneck, G. L. (2020) · Population Health Metrics · doi:10.1186/s12963-020-00203-6 · Cited by 31
Perumal, P., Abdullatif, M. B., Garlant, H. N., Honeyborne, I., Lipman, M. C. I., McHugh, T. D., Southern, J., Breen, R. A. M., Santis, G., Ellappan, K., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.612564 · Cited by 32
Identification of novel scaffolds targeting Mycobacterium tuberculosis
Molin, M. D., Selchow, P., Schäfle, D., Tschumi, A., Ryckmans, T., Laage-Witt, S., & Sander, P. (2019) · Journal of Molecular Medicine · doi:10.1007/s00109-019-01840-7 · Cited by 33
Epidemiological study of Mycobacterium Tuberculosis in Baghdad Governorate, Iraq
Aljanaby, A. A. J., Al-Faham, Q. M. H., Aljanaby, I. A. J., & Hasan, T. H. (2021) · Gene Reports · doi:10.1016/j.genrep.2021.101467 · Cited by 30
Sex and Gender Differences in Tuberculosis Pathogenesis and Treatment Outcomes
Dabitao, D., & Bishai, W. R. (2023) · Current topics in microbiology and immunology · doi:10.1007/978-3-031-35139-6_6 · Cited by 39
Moore, B. K., Graham, S. M., Nandakumar, S., Doyle, J., & Maloney, S. A. (2024) · Pathogens · doi:10.3390/pathogens13060467 · Cited by 38
Gene Regulatory Mechanism of Mycobacterium Tuberculosis during Dormancy
Liu, Y., Li, H., Dai, D., He, J., & Liang, Z. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46060348 · Cited by 29
Kim, E. W., Leon, A. A. D., Jiang, Z., Radu, R. A., Martineau, A. R., Chan, E. D., Bai, X., Su, W., Montoya, D. J., Modlin, R. L., et al. (2019) · mSphere · doi:10.1128/msphere.00327-19 · Cited by 30
Koeken, V. A. C. M., Verrall, A. J., Ardiansyah, E., Apriani, L., dos Santos, J. C., Kumar, V., Alisjahbana, B., Hill, P. C., Joosten, L. A. B., van Crevel, R., et al. (2019) · Journal of Leukocyte Biology · doi:10.1002/jlb.4ab0219-071r · Cited by 30
Harries, A. D., Kumar, A. M. V., Satyanarayana, S., Takarinda, K. C., Timire, C., & Dlodlo, R. A. (2019) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2020.1694907 · Cited by 34
Bekken, G. K., Ritz, C., Selvam, S., Jesuraj, N., Hesseling, A. C., Doherty, T. M., Grewal, H. M. S., Vaz, M. A. P., & Jenum, S. (2020) · BMC Infectious Diseases · doi:10.1186/s12879-020-4800-y · Cited by 30
Three Patients with COVID-19 and Pulmonary Tuberculosis, Wuhan, China, January–February 2020
Yao, Z. Q., Chen, J., Wang, Q., Liu, W., Zhang, Q., Nan, J., Hai, H., Wu, Y., Li, L., Liang, L., et al. (2020) · Emerging infectious diseases · doi:10.3201/eid2611.201536 · Cited by 30
Damene, H., Tahir, D., Diels, M., Berber, A., Sahraoui, N., & Rigouts, L. (2020) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0008894 · Cited by 30
Thindwa, D., MacPherson, P., Choko, A. T., Khundi, M., Sambakunsi, R., Ngwira, L. G., Kalua, T., Webb, E. L., & Corbett, E. L. (2018) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.17.0370 · Cited by 30
Neuroimmune recognition and regulation in the respiratory system
Chen, J., Lai, X., Song, Y., & Su, X. (2024) · European Respiratory Review · doi:10.1183/16000617.0008-2024 · Cited by 32
Tuberculosis Preventive Treatment in High TB-Burden Settings: A State-of-the-Art Review
Chihota, V. N., Gombe, M., Gupta, A., Salazar‐Austin, N., Ryckman, T. S., Hoffmann, C. J., LaCourse, S. M., Mathad, J. S., Mave, V., Dooley, K. E., et al. (2024) · Drugs · doi:10.1007/s40265-024-02131-3 · Cited by 29
Lukeman, H., Al-Wassiti, H. A., Fabb, S. A., Lim, L., Wang, T., Britton, W. J., Steain, M. C., Pouton, C. W., Triccas, J. A., & Counoupas, C. (2025) · EBioMedicine · doi:10.1016/j.ebiom.2025.105599 · Cited by 38
Prevalence of tuberculosis and multidrug resistant tuberculosis in the Middle East Region
Ahmad, S., Mokaddas, E. M., & Al-Mutairi, N. M. (2018) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2018.1519393 · Cited by 29
The Global Landscape of Tuberculosis Therapeutics
Tornheim, J. A., & Dooley, K. E. (2018) · Annual Review of Medicine · doi:10.1146/annurev-med-040717-051150 · Cited by 29
5-Year Follow-up of Active Tuberculosis Development From Latent Infection in Rural China
Xin, H., Zhang, H., Yang, S., Liu, J., Lu, W., Bai, L., Cao, X., Feng, B., Jin, Q., & Gao, L. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz581 · Cited by 29
Ma, J., Chen, X.-L., & Sun, Q. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.08.035 · Cited by 29
Awad, S. F., Critchley, J., & Abu-Raddad, L. J. (2019) · Epidemics · doi:10.1016/j.epidem.2019.100381 · Cited by 27
Pardhi, V. P., Suthar, T., Sharma, A., & Jain, K. (2022) · Nanomedicine · doi:10.2217/nnm-2022-0132 · Cited by 30
Applying Optimization Algorithms to Tuberculosis Antibiotic Treatment Regimens
Cicchese, J. M., Pienaar, E., Kirschner, D. E., & Linderman, J. J. (2017) · Cellular and Molecular Bioengineering · doi:10.1007/s12195-017-0507-6 · Cited by 28
Designing and Evaluating Interventions to Halt the Transmission of Tuberculosis
Dowdy, D. W., Grant, A. D., Dheda, K. U. J., Nardell, E. A., Fielding, K., & Moore, D. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix320 · Cited by 31
Qiu, X., Tang, Y., Yue, Y., Zeng, Y., Li, W., Qu, Y., & Mu, D. (2018) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2018.12.006 · Cited by 31
What will it take to eliminate drug-resistant tuberculosis?
Kendall, E. A., Sahu, S., Pai, M., Fox, G. J., Varaine, F., Cox, H. S., Cegielski, J. P., Mabote, L., Vassall, A., & Dowdy, D. W. (2019) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.18.0217 · Cited by 29
Cubillos-Angulo, J. M., Arriaga, M. B., Silva, E., Muller, B. L. A., Ramalho, D. M. D. P., Fukutani, K. F., Miranda, P. F. C., Moreira, A. S. R., Ruffino-Netto, A., Silva, J. R. L. E., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy1001 · Cited by 28
Tuberculosis and HIV co-infection in Congolese children: risk factors of death
Mukuku, O. K., Mutombo, A. M., Kakisingi, C. N., Musung, J. M., Wembonyama, S. O., & Luboya, O. N. (2019) · Pan African Medical Journal · doi:10.11604/pamj.2019.33.326.18911 · Cited by 28
Jain, P., Tiwari, A. K., & Som, T. (2020) · Soft Computing · doi:10.1007/s00500-020-05363-z · Cited by 28
Global Epidemiology of Tuberculosis
Glaziou, P., Sismanidis, C., & Floyd, K. (2021) · Springer eBooks · doi:10.1007/978-3-030-66703-0_37 · Cited by 28
Application of liposomes in the treatment of infectious diseases
Suhaimi, N. A. A., Ahmad, S., Husna, S. M. N., Sarmiento, M. E., Acosta, A., Norazmi, M. N., Ibrahim, J., Mohamud, R., & Kadir, R. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120734 · Cited by 28
Considerations for biomarker-targeted intervention strategies for tuberculosis disease prevention
Fiore-Gartland, A. J., Carpp, L. N., Naidoo, K., Thompson, E. G., Zak, D. E., Self, S. G., Churchyard, G., Walzl, G., Penn‐Nicholson, A., Scriba, T. J., et al. (2017) · Tuberculosis · doi:10.1016/j.tube.2017.11.009 · Cited by 28
Chang, S.-Y., Chen, M., Lee, M., Liang, Y., Lu, T., Wang, J., & Yan, B. (2018) · Disease Markers · doi:10.1155/2018/4687380 · Cited by 28
Cough in pulmonary tuberculosis: Existing knowledge and general insights
Turner, R. D. (2019) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2019.01.008 · Cited by 28
Harries, A. D., Schwoebel, V., Monedero-Recuero, I., Aung, T. K., Chadha, S. S., Chiang, C.-Y., Conradie, F., Dongo, J. P., Heldal, E., Jensen, P. M., et al. (2019) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.18.0207 · Cited by 28
Moliva, J. I., Hossfeld, A. P., Canan, C. H., Dwivedi, V., Wewers, M. D., Beamer, G., Turner, J., & Torrelles, J. B. (2017) · Mucosal Immunology · doi:10.1038/mi.2017.80 · Cited by 27
Sohn, H., Kasaie, P., Kendall, E. A., Gomez, G. B., Vassall, A., Pai, M., & Dowdy, D. W. (2019) · BMC Medicine · doi:10.1186/s12916-019-1384-8 · Cited by 27
Impact of Effective Global Tuberculosis Control on Health and Economic Outcomes in the United States
Menzies, N. A., Bellerose, M., Testa, C., Swartwood, N. A., Malyuta, Y., Cohen, T., Marks, S. M., Hill, A. N., Date, A. A., Maloney, S. A., et al. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202003-0526oc · Cited by 27
Advances in Diagnostics and Drug Discovery against Resistant and Latent Tuberculosis Infection
Canales, C. S. C., Cazorla, J. I. M., Torres, A. H. F., Filardi, E. T. M., Filippo, L. D. D., da Costa, P. I., Roque‐Borda, C. A., & Pavan, F. R. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15102409 · Cited by 27
Estimating Long-term Tuberculosis Reactivation Rates in Australian Migrants
Dale, K., Trauer, J. M., Dodd, P. J., Houben, R. M. G. J., & Denholm, J. T. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz569 · Cited by 27
Self-citationDiabetes mellitus and latent tuberculosis infection: an updated meta-analysis and systematic review
Zhou, G., Guo, X., Cai, S., Zhang, Y., Zhou, Y., Long, R., Zhou, Y., Li, H., Chen, N., & Song, C. (2023) · BMC Infectious Diseases · doi:10.1186/s12879-023-08775-y · Cited by 26
Guo, T., Tian, S., Xin, H., Du, J., Cao, X., Feng, B., He, Y., He, Y., Wang, D., Zhang, B., et al. (2024) · Emerging Microbes & Infections · doi:10.1080/22221751.2024.2302852 · Cited by 25
Unveiling insights into bovine tuberculosis: A comprehensive review
Khairullah, A. R., Moses, I. B., Kusala, M. K. J., Tyasningsih, W., Ayuti, S. R., Rantam, F. A., Fauziah, I., Silaen, O. S. M., Puspitasari, Y., Aryaloka, S., et al. (2024) · Open Veterinary Journal · doi:10.5455/ovj.2024.v14.i6.2 · Cited by 26
Metadata
- Authors
- Houben, R. M. G. J., & Dodd, P. J.
- Affiliations
- London School of Hygiene & Tropical Medicine (GB)
- University of Sheffield (GB)
- Corresponding author
- Houben, Rein M. G. J.
- Venue
- PLOS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2016-10-25
- Volume
- 13
- Issue
- 10
- Pages
- e1002152
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- PMC
- PMC5079585
- OpenAlex
- W2533230523
- Cited by
- 2,054
- References
- 26
- Citations by year
- 2026: 160 · 2025: 259 · 2024: 242 · 2023: 243 · 2022: 208 · 2021: 237 · 2020: 257 · 2019: 205 · 2018: 167 · 2017: 67 · 2016: 5
- FWCI
- 22.73
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS Medicine (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Bill and Melinda Gates Foundation (US) (OPP1084276)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › HIV, TB, and STIs Epidemiology
- Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
- Keywords
- latent tuberculosis infection, global burden of disease, annual risk of infection, isoniazid-resistant tuberculosis, recent infection, End TB Strategy, Gaussian process regression, WHO regions, tuberculosis control, uncertainty quantification, demography
- MeSH terms
- Antitubercular Agents, Humans, Isoniazid, Mycobacterium tuberculosis, Risk, Global Health, Incidence, Prevalence, Tuberculosis, Multidrug-Resistant, Latent Tuberculosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
